Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Marina Klein and Bernard Robaire!
Spike in peanut and nut anaphylaxis in children at Halloween and Easter
New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year
$2M funding to mitigate COVID-19 impact on tuberculosis services
Dr. Madhukar Pai launches studies in India, Indonesia, Nigeria and Peru
Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill
Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery
From silent infection to rapid death: Why are some people more vulnerable to COVID-19?
Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases
New study of therapy options in metastatic melanoma
RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors
Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death